Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
3
×
alexion pharmaceuticals
cancer
deals
fda
investing
roche
san francisco blog main
san francisco top stories
89bio
abbvie
adrian krainer
alnylam pharmaceuticals
alzheimer europe conference
alzheimer's disease
amgen
astrazeneca
bain capital
biogen
biotech ipos
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer drugs
cancer immunotherapy
cerevel therapeutics
cobimetinib
convergence pharmaceuticals
crispr therapeutics
cystic fibrosis
detroit blog main
detroit top stories
What
drug
3
×
research
3
×
medicines
alzheimer’s
annual
assessed
attention
bio
biotech
cancer
caught
causing
communities
conference
despite
dicerna
disease
esmo
europe
eye
family
gene
germany
hardest
hepatitis
hit
hosted
hottest
hunters
intended
investment
ipo
munich
pay
pharma
pharmaceuticals
prices
producing
protein
proteins
Language
unset
Current search:
research
×
drug
×
" national top stories "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More